Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Login and Edit functionaility are currrently unavailable.

Xuesong Gu, Ph.D.

Co-Author

This page shows the publications co-authored by Xuesong Gu and Towia Libermann.
Connection Strength

2.084
  1. Reduced PDEF expression increases invasion and expression of mesenchymal genes in prostate cancer cells. Cancer Res. 2007 May 01; 67(9):4219-26.
    View in: PubMed
    Score: 0.363
  2. Meta-analysis of transcriptome data identifies a novel 5-gene pancreatic adenocarcinoma classifier. Oncotarget. 2016 Apr 26; 7(17):23263-81.
    View in: PubMed
    Score: 0.169
  3. Computational repositioning and preclinical validation of pentamidine for renal cell cancer. Mol Cancer Ther. 2014 Jul; 13(7):1929-1941.
    View in: PubMed
    Score: 0.148
  4. Combinatorial effect of non-steroidal anti-inflammatory drugs and NF-?B inhibitors in ovarian cancer therapy. PLoS One. 2011; 6(9):e24285.
    View in: PubMed
    Score: 0.123
  5. JunD-mediated repression of GADD45a and ? regulates escape from cell death in prostate cancer. Cell Cycle. 2011 Aug 01; 10(15):2583-91.
    View in: PubMed
    Score: 0.122
  6. Requirement of the epithelium-specific Ets transcription factor Spdef for mucous gland cell function in the gastric antrum. J Biol Chem. 2010 Nov 05; 285(45):35047-55.
    View in: PubMed
    Score: 0.114
  7. A novel pathway involving melanoma differentiation associated gene-7/interleukin-24 mediates nonsteroidal anti-inflammatory drug-induced apoptosis and growth arrest of cancer cells. Cancer Res. 2006 Dec 15; 66(24):11922-31.
    View in: PubMed
    Score: 0.089
  8. Gene signatures of progression and metastasis in renal cell cancer. Clin Cancer Res. 2005 Aug 15; 11(16):5730-9.
    View in: PubMed
    Score: 0.081
  9. The Ets transcription factor ESE-1 mediates induction of the COX-2 gene by LPS in monocytes. FEBS J. 2005 Apr; 272(7):1676-87.
    View in: PubMed
    Score: 0.079
  10. Isoforms of the Ets transcription factor NERF/ELF-2 physically interact with AML1 and mediate opposing effects on AML1-mediated transcription of the B cell-specific blk gene. J Biol Chem. 2004 May 07; 279(19):19512-22.
    View in: PubMed
    Score: 0.073
  11. Responses to the proinflammatory cytokines interleukin-1 and tumor necrosis factor alpha in cells derived from rheumatoid synovium and other joint tissues involve nuclear factor kappaB-mediated induction of the Ets transcription factor ESE-1. Arthritis Rheum. 2003 May; 48(5):1249-60.
    View in: PubMed
    Score: 0.069
  12. Parenteral lipid emulsions induce unique ileal fatty acid and metabolomic profiles but do not increase the risk of necrotizing enterocolitis in preterm pigs. Am J Physiol Gastrointest Liver Physiol. 2021 02 01; 320(2):G227-G239.
    View in: PubMed
    Score: 0.058
  13. Neutrophil activation in systemic capillary leak syndrome (Clarkson disease). J Cell Mol Med. 2019 08; 23(8):5119-5127.
    View in: PubMed
    Score: 0.053
  14. Dihydroartemisinin inhibits prostate cancer via JARID2/miR-7/miR-34a-dependent downregulation of Axl. Oncogenesis. 2019 Feb 19; 8(3):14.
    View in: PubMed
    Score: 0.051
  15. Noninvasive exosomal proteomic biosignatures, including cystatin SN, peroxiredoxin-5, and glycoprotein VI, accurately predict chronic rhinosinusitis with nasal polyps. Int Forum Allergy Rhinol. 2019 02; 9(2):177-186.
    View in: PubMed
    Score: 0.051
  16. Increased levels of circulating MMP3 correlate with severe rejection in face transplantation. Sci Rep. 2018 10 08; 8(1):14915.
    View in: PubMed
    Score: 0.050
  17. Stability and reproducibility of proteomic profiles measured with an aptamer-based platform. Sci Rep. 2018 05 30; 8(1):8382.
    View in: PubMed
    Score: 0.049
  18. Tie2 protects the vasculature against thrombus formation in systemic inflammation. J Clin Invest. 2018 04 02; 128(4):1471-1484.
    View in: PubMed
    Score: 0.048
  19. GADD45a and ? interaction with CDK11p58 regulates SPDEF protein stability and SPDEF-mediated effects on cancer cell migration. Oncotarget. 2016 Mar 22; 7(12):13865-79.
    View in: PubMed
    Score: 0.042
  20. Creating a "pro-survival" phenotype through epigenetic modulation. Surgery. 2012 Sep; 152(3):455-64.
    View in: PubMed
    Score: 0.033
  21. Nna1 mediates Purkinje cell dendritic development via lysyl oxidase propeptide and NF-?B signaling. Neuron. 2010 Oct 06; 68(1):45-60.
    View in: PubMed
    Score: 0.029
  22. ESE-1 is a potent repressor of type II collagen gene (COL2A1) transcription in human chondrocytes. J Cell Physiol. 2008 May; 215(2):562-73.
    View in: PubMed
    Score: 0.024
  23. Essential role of Jun family transcription factors in PU.1 knockdown-induced leukemic stem cells. Nat Genet. 2006 Nov; 38(11):1269-77.
    View in: PubMed
    Score: 0.022
  24. Antimyeloma activity of heat shock protein-90 inhibition. Blood. 2006 Feb 01; 107(3):1092-100.
    View in: PubMed
    Score: 0.020
  25. Gene expression signature with independent prognostic significance in epithelial ovarian cancer. J Clin Oncol. 2004 Dec 01; 22(23):4700-10.
    View in: PubMed
    Score: 0.019
  26. NF-kappa B-mediated repression of growth arrest- and DNA-damage-inducible proteins 45alpha and gamma is essential for cancer cell survival. Proc Natl Acad Sci U S A. 2004 Sep 14; 101(37):13618-23.
    View in: PubMed
    Score: 0.019
  27. ESE-1 is a novel transcriptional mediator of angiopoietin-1 expression in the setting of inflammation. J Biol Chem. 2004 Mar 26; 279(13):12794-803.
    View in: PubMed
    Score: 0.018
  28. Transcriptional signature of histone deacetylase inhibition in multiple myeloma: biological and clinical implications. Proc Natl Acad Sci U S A. 2004 Jan 13; 101(2):540-5.
    View in: PubMed
    Score: 0.018
  29. Constitutive and cytokine-induced expression of the ETS transcription factor ESE-3 in the lung. Am J Respir Cell Mol Biol. 2002 Dec; 27(6):697-704.
    View in: PubMed
    Score: 0.017
  30. The proteasome inhibitor PS-341 potentiates sensitivity of multiple myeloma cells to conventional chemotherapeutic agents: therapeutic applications. Blood. 2003 Mar 15; 101(6):2377-80.
    View in: PubMed
    Score: 0.017
  31. Molecular sequelae of proteasome inhibition in human multiple myeloma cells. Proc Natl Acad Sci U S A. 2002 Oct 29; 99(22):14374-9.
    View in: PubMed
    Score: 0.017
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.